AC Immune Awarded New Grants From MJFF, Target ALS Supporting Programs Targeting TDP-43

The Michael J. Fox Foundation grant supports the development of AC Immune's first-in-class TDP-43 PET tracer program Target ALS Foundation grant supports collaboration between AC Immune and world-class

byBenzinga Newsdesk

February 7, 2023

1 minute read

The Michael J. Fox Foundation grant supports the development of AC Immune’s first-in-class TDP-43 PET tracer program
- Target ALS Foundation grant supports collaboration between AC Immune and world-class institutions to accelerate the development of novel biofluid assays for detecting TDP-43-related neuropathologyA

Celldex Therapeutics Q1 EPS $(0.49) Down From $(0.42) YoY, Sales $200.00K Down From $685.00K YoY

By Benzinga Newsdesk

Today, 9:47 AM

Celldex Therapeutics (NASDAQ:CLDX) reported quarterly losses of $(0.49) per share. This is a 16.67 percent decrease over losses of $(0.42) per share from the same period last year. The company reported $200.00 thousand

CLDX

Wedbush Maintains Outperform on Hyzon Motors, Lowers Price Target to $11

By Benzinga Newsdesk

Today, 9:47 AM

Wedbush maintains Hyzon Motors (NASDAQ:HYZN) with a Outperform and lowers the price target from $15 to $11.

HYZN

A Look Into Phibro Animal Health’s Debt

By Benzinga Insights

Today, 9:47 AM

Shares of Phibro Animal Health (NASDAQ:PAHC) moved lower by 10.41% in the past three months. Before we understand the importance of debt, let us look at how much debt Phibro Animal Health has.

PAHC